Immunorepertoire normality assessment method and its use
US11047011B2 · kind B2 · utility
1Cited by
1References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 28, 2016 |
| Grant date | Jun 29, 2021 |
| Priority date | — |
| Expiry date | Mar 24, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/16
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present disclosure generally pertains to a method for comparing the immunorepertoire diversity of a patient to the shared immunorepertoire of a group of individuals to identify whether the immunorepertoire diversity of the patient is normal or abnormal relative to the shared immunorepertoire of the group of individuals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.